Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3)

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 5244-5248

  Hammache, Djilali ^a   Yahi, Nouara ^b   Maresca, Marc ^a   Piéroni, Gérard ^c   Fantini, Jacques ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLERA TOXIN; GANGLIOSIDE GM3; GLOBOTRIAOSYLCERAMIDE; GLYCOPROTEIN GP 120; GLYCOSPHINGOLIPID; VIRUS ENVELOPE PROTEIN;

ARTICLE; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PRIORITY JOURNAL; PROTEIN INTERACTION;

EID: 0032994918     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.5244-5248.1999     Document Type: Article

References (30)

1. Berger, E. A., R. W. Doms, E. M. Fenyo, B. T. M. Korber, D. R. Littman, J. P. Moore, Q. J. Sattentau, H. Schuitemaker, and J. Sodroski. 1998. A new classification for HIV-1. Nature 391:240.
2. Binley, J., and J. P. Moore. 1997. The viral mousetrap. Nature 387:346-348.
3. Clapham, P. R., and R. A. Weiss. 1997. Spoilt for choice of coreceptors. Nature 388:230-231.
4. Cumar, F. A., B. Maggio, and R. Caputto. 1982. Ganglioside-cholera toxin interactions: a binding and lipid monolayer study. Mol. Cell. Biochem. 46: 155-160.
5. Delézay, O., D. Hammache, J. Fantini, and N. Yahi. 1996. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry 35:15663-15671.
6. Deng, H. K., S. Choe, W. Ellmeier, R. Liu, D. Unumatz, M. Burkhart, P. Di Marzio, S. Marmon, R E. Sutton, C. M. Hill, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of C-C chemokine receptor 5 as the major coreceptor for entry of macrophage-tropic human immunodeficiency virus type 1. Nature 381:661-666.
7. Dimitrov, D. S. 1997. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 91:721-730.
8. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
9. Dragic, T., L. Picard, and M. Alizon. 1995. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 69:1013-1018.
10. Fantini, J., C. Tamalet, D. Hammache, C. Tourrès, N. Duclos, and N. Yahi. 1998. HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 19:221-229.
11. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877.
12. Hakomori, S., and R. Kannagi. 1986. Carbohydrate antigens in higher animals, p. 9.1-9.36. In D. M. Weir (ed.), Handbook of experimental immunology, vol. 1. Immunochemistry. Blackwell Scientific Publications, Oxford, United Kingdom.
13. Hammache, D., G. Piéroni, N. Yahi, O. Delézay, N. Koch, H. Lafont, C. Tamalet, and J. Fantini. 1998. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273:7967-7971.
14. Hammache, D., N. Yahi, G. Piéroni, F. Ariasi, C. Tamalet, and J. Fantini. 1998. Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. Biochem. Biophys. Res. Commun. 246: 117-122.
15. Haywood, A. M. 1994. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J. Virol. 68:1-5.
16. Jones, P. L., T. Korte, and R. Blumenthal. 1998. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273:404-409.
17. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
18. Maggio, B., F. A. Cnmar, and R. Caputto. 1978. Surface behaviour of gangliosides and related glycosphingolipids. Biochem. J. 171:559-565.
19. Paxton, W. A., T. Dragic, R. A. Koup, and J. P. Moore. 1996. The β-chemokines, HIV type 1 second receptors, and exposed uninfected persons. AIDS Res. Hum. Retroviruses 12:1203-1207.
20. Pellizzari, A., H. Pang, and C. A. Lingwood. 1992. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry 31:1363-1370.
21. Puri, A., S. J. Morris, P. Jones, M. Ryan, and R. Blumenthal. 1996. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins. Virology 219: 262-267.
22. + cells. Biochem. Biophys. Res. Commun. 242:219-225.
23. Puri, A., P. Hug, K. Jernigan, J. Barchi, H.-Y. Kim, J. Hamilton, J. Wiels, G. J. Murray, R. O. Brady, and R. Blumenthal. 1998. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 95:14435-14440.
24. Rucker, J., A. L. Edinger, M. Sharron, M. Samson, B. Lee, J. F. Berson, Y. Yi, B. Margulies, R. G. Collman, B. J. Doranz, M. Parmentier, and R. W. Doms. 1997. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71:8999-9007.
25. Sato, T., T. Serizawa, and Y. Okhata. 1996. Binding of influenza A virus to monosialoganglioside (GM3) reconstituted in glucosylceramide and sphingomyelin membranes. Biochim. Biophys. Acta 1285:14-20.
26. Simmons, G., D. Wilkinson, J. D. Reeves, M. T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W. Gray, R. A. Weiss, and P. R. Clapham. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-8360.
27. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572.
28. Sorice, M., I. Parolini, T. Sansolini, T. Garofalo, V. Dolo, M. Sargiacomo, T. Tai, C. Peschle, M. R. Torrisi, and A. Pavan. 1997. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid Res. 38:969-980.
29. Spitalnik, P. F., J. M. Danley, S. R. Burger, and S. L. Spitalnik. 1989. The glycosphingolipid composition of the human hepatoma cell line, Hep-G2. Arch. Biochem. Biophys. 273:578-591.
30. Tamma, S. L., S. K. Sundaram, M. Lev, and R. F. Colco. 1996. Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphotna cells. Biochem. Biophys. Res. Commun. 220:916-921.